Developer docs
API playgroundTry for free, no card

Search company profiles

Akadeum Life Sciences

Full company profile

uuid0000651

Namestring
Akadeum Life Sciences
Legal namestring
Akadeum Life Sciences
Websiteurl
akadeum.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Akadeum Life Sciences is a privately held life sciences tools company founded in 2014 and headquartered in Ann Arbor, Michigan, that develops and commercializes proprietary buoyant microbubble-based cell separation products for cell therapy developers, CDMOs, and life science researchers. The company's core technology, BACS (Buoyancy-Activated Cell Sorting), uses hollow silica microbubbles (averaging 12 microns) functionalized with antibodies to selectively bind and float unwanted cells, enabling negative selection that leaves target cells untouched without magnets, columns, or centrifugation. This is described as the first new cell separation modality in over 40 years, with demonstrated superiority in cell viability (97%+), purity (93-97% CD3+), throughput (up to 50+ billion cells per run), processing time (up to 80% reduction), and manufacturing cost (up to 40% reduction) versus traditional magnetic methods.

The company monetizes through a multi-tiered model: research-use kits sold via e-commerce at $480-$1,066 per kit (human and mouse T cell, B cell, monocyte, PBMC, dead cell, and RBC depletion kits), quote-based GMP-grade kits for clinical manufacturing (Human T Cell Leukopak Isolation Kit – GMP, Human T Cell Depletion Kit – GMP), and the Alerion automated cell separation system as a hardware sale. Distribution is global through direct enterprise sales, a Cayman Chemical distribution partnership, the Akadeum CDMO Alliance (Charles River, ElevateBio), and validated integrations with seven major cell therapy platforms (Thermo Fisher Rotea, Cytiva Sepax, Fresenius Kabi Cue, Wilson Wolf G-Rex, Octane Biotech Cocoon, MaxCyte ExPERT GTx, Limula LimONE). The company has submitted a Type II Drug Master File to the FDA, operates under ISO 13485 and 21 CFR 820 GMP compliance, and has raised approximately $37.5M+ in cumulative funding across multiple rounds, including a $17.5M Series B (2021) and a $20M+ round (2025) led by Michigan Capital Network.

Short descriptiontext

Akadeum Life Sciences develops proprietary buoyant microbubble (BACS) cell separation kits and the Alerion system for cell therapy developers, CDMOs, and life science researchers, enabling gentle, scalable, closed-system cell isolation without magnets or columns.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAnn Arbor, United States
HQ citystring
Ann Arbor
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cell separation technology, cell therapy products, buoyant microbubble kits, bioseparation products, GMP cell isolation
Industry4 codes
PRIMARYHLAAABAG
Cell Therapy Manufacturing Platforms & Automation (closed systems, bioreactors, fill-finish)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)
SECONDARYHLAAAKAC
Cell Therapy Manufacturing Services (GMP, autologous/allogeneic)
SECONDARYHLAGAIAC
General Lab Equipment (Centrifuges, Incubators, Shakers, Ovens)
SECONDARYHLAAAJAB
Downstream Processing & Purification Technologies (chromatography, filtration, centrifugation)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
NAICS code1 code
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Cell Separation Technology
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Cell Separation Kits (RUO and GMP)
TypeOne Time License
Description

Sale of microbubble-based cell separation kits for research use (RUO) and clinical manufacturing (GMP grade). Products include T cell isolation kits, T cell depletion kits, PBMC isolation kits, dead cell removal kits, and specialized cell type isolation kits. Available in various scales from research to leukopak scale.

akadeum.com
2Alerion Cell Separation System
TypeHardware Sales
Description

Sale of the Alerion automated microbubble cell separation system for higher throughput applications in research through clinical settings.

akadeum.com
3CDMO Alliance Services
TypeLicensing Royalties
Description

Partnership model with contract development and manufacturing organizations (CDMOs) who integrate Akadeum's GMP microbubble kits into their cell therapy manufacturing services.

akadeum.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Others
Pricing details6 tiers
1Dead Cell Removal Microbubble Kit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$603.00 USD per kit

akadeum.com
2Human CD14+ Monocyte Isolation Kit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$1,066.00 USD per kit

akadeum.com
3Mouse B Cell Isolation Kit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$765.00 USD per kit

akadeum.com
4Streptavidin Microbubbles
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$572.00 USD per kit

akadeum.com
5Human Red Blood Cell Depletion Microbubbles
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$480.00 USD per kit

akadeum.com
6Human T Cell Leukopak Isolation Kit (RUO and GMP)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Quote-based pricing for GMP products; evaluation program with discounted kits available

akadeum.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Alerion™
Description

Microbubble Cell Separation System - a scalable, fast, and efficient cell isolation system for research through clinical settings.

akadeum.com
+2 more records
Core offering1 text field

Akadeum Life Sciences develops and manufactures buoyant microbubble-based cell separation products, including GMP-grade and research-use kits for T cell, B cell, monocyte, and PBMC isolation, plus the Alerion automated cell separation system. Its proprietary BACS (Buoyancy-Activated Cell Sorting) technology enables negative selection at clinical scale without magnets or centrifugation, supporting cell therapy manufacturing, CAR-T culture cleanup, and immunology research applications.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 40% reduction in overall therapeutic manufacturing costs
+6 more records
Product overview1 text field

Akadeum Life Sciences offers a comprehensive portfolio of buoyant microbubble cell separation products centered on its proprietary BACS (Buoyancy-Activated Cell Sorting) technology platform. The platform provides the first new cell separation modality in over 40 years, using gentle flotation instead of magnets or columns. The product line spans three main categories: GMP-grade cell therapy products for clinical manufacturing (Human T Cell Leukopak Isolation Kit – GMP, Human T Cell Depletion Kit – GMP), Research Use Only (RUO) cell therapy products, and research-scale immunology products for human and mouse species including T cell, B cell, monocyte, and PBMC isolation kits. Key products include the Alerion Microbubble Cell Separation System for automated scalable processing, Dead Cell Removal Kit, and Streptavidin Microbubbles for custom applications. The technology enables negative selection at clinical scale (50+ billion cells per run) with demonstrated 40% cost savings and 80% time savings versus traditional magnetic methods.

Product and service19 records
1Alerion Microbubble Cell Separation System
CategoryCell Separation Instruments
Description

Automated benchtop system for microbubble-based cell separation that delivers scalable, fast, and efficient cell isolation with capacity from 50 million to over 50 billion cells per run.

2Human T Cell Leukopak Isolation Kit – GMP
CategoryGMP Cell Therapy Products
Description

GMP-grade negative selection kit that isolates untouched T cells from leukopak material using buoyant microbubbles for clinical-scale cell therapy manufacturing, enabling up to 40% cost reduction versus magnetic methods.

3Human T Cell Leukopak Isolation Kit (RUO)
CategoryResearch Use Only Cell Therapy Products
Description

Research-use-only negative selection kit for isolating T cells from human leukopak samples using buoyant microbubble technology without magnetic columns or specialized equipment.

4Human T Cell Depletion Kit – GMP
CategoryGMP Cell Therapy Products
Description

GMP-grade depletion kit that removes CD3+ T cells from cell therapy workflows, leaving behind highly pure engineered cells for downstream formulation in CAR-T culture cleanup applications.

5Human T Cell Depletion Kit (RUO)
CategoryResearch Use Only Cell Therapy Products
Description

RUO-grade kit for removing unwanted CD3+ T cells from samples, enabling cleaner engineered cell populations for research and process development applications.

6Human PBMC Leukopak Isolation Kit
CategoryResearch Cell Isolation Kits
Description

Kit for isolating peripheral blood mononuclear cells from leukopak samples using buoyant microbubble technology, providing fast and gentle cell separation with high viability.

7Human T Cell Isolation Kit
CategoryResearch Cell Isolation Kits
Description

Standard-scale kit for isolating T cells from human samples using buoyant microbubble technology, suitable for smaller cell input quantities in research settings.

8Human CD4+ T Cell Isolation Kit
CategoryResearch Cell Isolation Kits
Description

Kit for isolating CD4+ helper T cells from human samples using negative selection microbubble technology without requiring magnetic columns.

9Human CD14+ Monocyte Isolation Kit
CategoryResearch Cell Isolation Kits
Description

Kit for isolating CD14+ monocytes from human peripheral blood samples using antibody-functionalized buoyant microbubbles for rapid, gentle separation.

10Human B Cell Isolation Kit
CategoryResearch Cell Isolation Kits
Description

Kit for isolating B cells from human samples using buoyant microbubble negative selection technology that preserves cell health and physiology.

11Dead Cell Removal Microbubble Kit
CategorySample Purification Products
Description

Kit utilizing Annexin V-coated microbubbles to selectively bind phosphatidylserine on dead cells, enabling removal of apoptotic cells from samples while preserving viable cell populations.

12Human Red Blood Cell Depletion Microbubbles
CategorySample Purification Products
Description

Microbubble kit for depleting red blood cells from human samples using buoyant separation technology, enabling rapid removal of RBC contamination.

13Streptavidin Microbubbles
CategorySample Purification Products
Description

Streptavidin-coated buoyant microbubbles that can be paired with biotinylated antibodies for custom cell separation applications, providing flexible labeling and separation capability.

14Mouse T Cell Isolation Kit
CategoryResearch Cell Isolation Kits
Description

Kit for isolating T cells from mouse spleen or lymph node samples using negative selection microbubble technology at research scale.

15Mouse B Cell Isolation Kit
CategoryResearch Cell Isolation Kits
Description

Kit for isolating B cells from mouse spleen samples using buoyant microbubble negative selection that maintains cell physiology without harsh mechanical forces.

16Mouse CD4+ Isolation Kit
CategoryResearch Cell Isolation Kits
Description

Kit for isolating CD4+ T cells from mouse samples using microbubble-based negative selection at research scale.

17Mouse Naive T Cell Isolation Kit
CategoryResearch Cell Isolation Kits
Description

Research-scale kit for isolating naive T cells from mouse samples using negative selection microbubble technology.

18Mouse Naive CD4+ T Cell Isolation Kit
CategoryResearch Cell Isolation Kits
Description

Kit for isolating naive CD4+ T cells from mouse samples using buoyant microbubble technology without magnetic separation.

19Human T Cell Selection, Activation, and Expansion Kit
CategoryCell Therapy Workflow Kits
Description

Kit combining T cell selection via microbubbles with activation and expansion reagents for a streamlined cell therapy workflow from selection through culture.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-12-09
Description

Charles River is an inaugural member of the Akadeum CDMO Alliance Program, integrating GMP microbubble kits into their cell therapy manufacturing services. Collaboration includes application notes demonstrating workflow compatibility, efficiency, and performance comparing microbubble-based isolation against traditional magnetic methods.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-12-09
Description

ElevateBio is an inaugural member of the Akadeum CDMO Alliance Program, offering cell therapy manufacturing services using Akadeum's GMP microbubble technology with early access to new kits in development.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-01
Description

Strategic collaboration to provide higher-quality T cells for cell therapy development, focusing on better-qualified leukopak materials. The microbubble-based separation process results in healthier T cells and more consistent workflow results.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-09-25
Description

Distribution partnership enabling Cayman Chemical to distribute Akadeum's buoyant microbubble cell isolation kits globally, expanding researcher access to this technology for advancing cell and gene therapy development.

Strategic tierCoreTypeTechnology or Integration
Description

Integration of Akadeum's GMP microbubble kits with Thermo Fisher's Rotea Counterflow Centrifugation System for automated cell washing, buffer exchange, and concentration workflows in cell therapy manufacturing.

Strategic tierCoreTypeTechnology or Integration
Description

Integration with Cytiva's Sepax C-Pro Cell Processing System demonstrating high purity and recovery for CAR-T manufacturing workflows. NIH study also validated microbubble isolation with Sepax NeatCell protocol.

Strategic tierCoreTypeTechnology or Integration
Description

Integration with Fresenius Kabi's Cue Cell Processing System for automated platelet depletion combined with Akadeum's in-bag T cell isolation, demonstrating equivalent performance to magnetic methods in half the time.

Strategic tierCoreTypeTechnology or Integration
Description

Integration with Wilson Wolf G-Rex Bioreactor Platform for instrument-free, closed-system T cell isolation upstream of culture expansion. Microbubbles maintain T cell memory plasticity phenotypes important to therapeutic relevance.

Strategic tierCoreTypeTechnology or Integration
Description

Integration with Octane Biotech Cocoon Platform for fully automated T cell enrichment from cryopreserved leukopaks, achieving 88-97% CD3+ purity and 50-86% recovery without magnets or beads.

Strategic tierCoreTypeTechnology or Integration
Description

Integration with MaxCyte ExPERT GTx Electroporation Instrument demonstrating that microbubble-isolated cells show improved post-electroporation viability, higher expansion, and preserved stem-cell-like memory phenotypes.

Strategic tierCoreTypeTechnology or Integration
Description

Integration with Limula LimONE Platform for fully automated, closed T cell enrichment embedded within end-to-end CAR-T workflow. Achieves PBMC-to-activation in approximately 1 hour 45 minutes within closed system.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

The dominant incumbent in magnetic-activated cell sorting (MACS), Miltenyi sells separation reagents, instruments, and GMP cell therapy manufacturing services that directly compete with Akadeum's microbubble kits for T cell, B cell, and PBMC isolation in clinical and commercial cell therapy workflows.

TypeBroad incumbent
Description

Sells Dynabeads magnetic separation reagents and the Rotea counterflow centrifugation system integrated with Akadeum's kits; competes at the cell processing instrument and consumables layer across the cell therapy manufacturing value chain.

TypeDirect peer
Description

Provides EasySep immunomagnetic cell separation kits for research and GMP-grade cell isolation; directly competes with Akadeum's RUO and GMP cell separation kits across T cell, B cell, monocyte, and PBMC isolation applications.

TypeBroad incumbent
Description

Supplies the Sepax C-Pro cell processing system integrated with Akadeum's microbubble kits for CAR-T manufacturing; also offers competing cell processing instruments and consumables broadly used across the cell therapy manufacturing space.

TypeBroad incumbent
Description

A Danaher-owned life science tools provider offering cell sorting instrumentation (CytoFLEX, MoFlo Astrios) and reagents; competes as an incumbent in the broader cell separation and analysis category relevant to Akadeum's customer base.

TypeBroad incumbent
Description

Supplies FACSDiscover and BD CellView image-enabled cell sorters plus a broad reagents portfolio; an incumbent in cell sorting and separation used by Akadeum's customer base of cell therapy developers and CDMOs.

TypeDirect peer
Description

Provides the ExPERT GTx electroporation platform for cell engineering that integrates upstream/downstream with Akadeum's microbubble kits; overlapping footprint in GMP cell therapy manufacturing workflows and a complementary (rather than purely substitutive) peer.

TypeDirect peer
Description

Manufacturer of G-Rex bioreactors used in cell therapy expansion that integrate with Akadeum's microbubble isolation kits; comparable as a focused cell therapy bioprocessing platform vendor serving the same customer base.

TypeBroad incumbent
Description

Sells cell separation and culture reagents (including the original T Cell Activation/Expansion portfolio) through its ProteinSimple and R&D Systems brands; an established life science tools incumbent overlapping with Akadeum's research and GMP reagent lines.

10Sony Biotechnology
TypeEmerging player
Description

Supplies the CGX10 cell isolation system and MA900 multi-application cell sorter; a specialized cell separation instrumentation vendor with overlapping but more focused market presence compared to Akadeum's microbubble consumables approach.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration7 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance11 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds12 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors17 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Akadeum Life Sciences

Cell Separation Technologyakadeum.com

Akadeum Life Sciences develops proprietary buoyant microbubble (BACS) cell separation kits and the Alerion system for cell therapy developers, CDMOs, and life science researchers, enabling gentle, scalable, closed-system cell isolation without magnets or columns.

What Akadeum Life Sciences does

Akadeum Life Sciences is a privately held life sciences tools company founded in 2014 and headquartered in Ann Arbor, Michigan, that develops and commercializes proprietary buoyant microbubble-based cell separation products for cell therapy developers, CDMOs, and life science researchers. The company's core technology, BACS (Buoyancy-Activated Cell Sorting), uses hollow silica microbubbles (averaging 12 microns) functionalized with antibodies to selectively bind and float unwanted cells, enabling negative selection that leaves target cells untouched without magnets, columns, or centrifugation. This is described as the first new cell separation modality in over 40 years, with demonstrated superiority in cell viability (97%+), purity (93-97% CD3+), throughput (up to 50+ billion cells per run), processing time (up to 80% reduction), and manufacturing cost (up to 40% reduction) versus traditional magnetic methods.

The company monetizes through a multi-tiered model: research-use kits sold via e-commerce at $480-$1,066 per kit (human and mouse T cell, B cell, monocyte, PBMC, dead cell, and RBC depletion kits), quote-based GMP-grade kits for clinical manufacturing (Human T Cell Leukopak Isolation Kit – GMP, Human T Cell Depletion Kit – GMP), and the Alerion automated cell separation system as a hardware sale. Distribution is global through direct enterprise sales, a Cayman Chemical distribution partnership, the Akadeum CDMO Alliance (Charles River, ElevateBio), and validated integrations with seven major cell therapy platforms (Thermo Fisher Rotea, Cytiva Sepax, Fresenius Kabi Cue, Wilson Wolf G-Rex, Octane Biotech Cocoon, MaxCyte ExPERT GTx, Limula LimONE). The company has submitted a Type II Drug Master File to the FDA, operates under ISO 13485 and 21 CFR 820 GMP compliance, and has raised approximately $37.5M+ in cumulative funding across multiple rounds, including a $17.5M Series B (2021) and a $20M+ round (2025) led by Michigan Capital Network.

Akadeum Life Sciences firmographics

Firmographics
Name
Akadeum Life Sciences
Legal name
Akadeum Life Sciences
Website
https://akadeum.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
Akadeum Life Sciences develops proprietary buoyant microbubble (BACS) cell separation kits and the Alerion system for cell therapy developers, CDMOs, and life science researchers, enabling gentle, scalable, closed-system cell isolation without magnets or columns.
Ownership category
akta.pro rank

Akadeum Life Sciences industry classification

Industry
Product category
Cell Separation Technology
NAICS
Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAAABAG
Cell Therapy Manufacturing Platforms & Automation (closed systems, bioreactors, fill-finish)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)
SECONDARYHLAAAKAC
Cell Therapy Manufacturing Services (GMP, autologous/allogeneic)
SECONDARYHLAGAIAC
General Lab Equipment (Centrifuges, Incubators, Shakers, Ovens)
SECONDARYHLAAAJAB
Downstream Processing & Purification Technologies (chromatography, filtration, centrifugation)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)

Keywords

  • Cell separation technology
  • Cell therapy products
  • Buoyant microbubble kits
  • Bioseparation products
  • GMP cell isolation

Where Akadeum Life Sciences is headquartered

Location

Headquarters

HQ city
Ann Arbor
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Akadeum Life Sciences business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Others

Revenue model

  1. Cell Separation Kits (RUO and GMP): Sale of microbubble-based cell separation kits for research use (RUO) and clinical manufacturing (GMP grade). Products include T cell isolation kits, T cell depletion kits, PBMC isolation kits, dead cell removal kits, and specialized cell type isolation kits. Available in various scales from research to leukopak scale.
  2. Alerion Cell Separation System: Sale of the Alerion automated microbubble cell separation system for higher throughput applications in research through clinical settings.
  3. CDMO Alliance Services: Partnership model with contract development and manufacturing organizations (CDMOs) who integrate Akadeum's GMP microbubble kits into their cell therapy manufacturing services.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goDead Cell Removal Microbubble Kit
Unit PricingPay-as-you-goHuman CD14+ Monocyte Isolation Kit
Unit PricingPay-as-you-goMouse B Cell Isolation Kit
Unit PricingPay-as-you-goStreptavidin Microbubbles
Unit PricingPay-as-you-goHuman Red Blood Cell Depletion Microbubbles
Unit PricingPay-as-you-goHuman T Cell Leukopak Isolation Kit (RUO and GMP)

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Akadeum Life Sciences product offering

Product offering

Core offering

Akadeum Life Sciences develops and manufactures buoyant microbubble-based cell separation products, including GMP-grade and research-use kits for T cell, B cell, monocyte, and PBMC isolation, plus the Alerion automated cell separation system. Its proprietary BACS (Buoyancy-Activated Cell Sorting) technology enables negative selection at clinical scale without magnets or centrifugation, supporting cell therapy manufacturing, CAR-T culture cleanup, and immunology research applications.

Product overview

Akadeum Life Sciences offers a comprehensive portfolio of buoyant microbubble cell separation products centered on its proprietary BACS (Buoyancy-Activated Cell Sorting) technology platform. The platform provides the first new cell separation modality in over 40 years, using gentle flotation instead of magnets or columns. The product line spans three main categories: GMP-grade cell therapy products for clinical manufacturing (Human T Cell Leukopak Isolation Kit – GMP, Human T Cell Depletion Kit – GMP), Research Use Only (RUO) cell therapy products, and research-scale immunology products for human and mouse species including T cell, B cell, monocyte, and PBMC isolation kits. Key products include the Alerion Microbubble Cell Separation System for automated scalable processing, Dead Cell Removal Kit, and Streptavidin Microbubbles for custom applications. The technology enables negative selection at clinical scale (50+ billion cells per run) with demonstrated 40% cost savings and 80% time savings versus traditional magnetic methods.

Differentiator

Problem solved

Functional benefit

Brands

  • Alerion™: Microbubble Cell Separation System - a scalable, fast, and efficient cell isolation system for research through clinical settings.
  • BACS™ (Buoyancy-Activated Cell Sorting)
  • Akadeum CDMO Alliance

Products and services

  • Alerion Microbubble Cell Separation System Automated benchtop system for microbubble-based cell separation that delivers scalable, fast, and efficient cell isolation with capacity from 50 million to over 50 billion cells per run.
  • Human T Cell Leukopak Isolation Kit – GMP GMP-grade negative selection kit that isolates untouched T cells from leukopak material using buoyant microbubbles for clinical-scale cell therapy manufacturing, enabling up to 40% cost reduction versus magnetic methods.
  • Human T Cell Leukopak Isolation Kit (RUO) Research-use-only negative selection kit for isolating T cells from human leukopak samples using buoyant microbubble technology without magnetic columns or specialized equipment.
  • Human T Cell Depletion Kit – GMP GMP-grade depletion kit that removes CD3+ T cells from cell therapy workflows, leaving behind highly pure engineered cells for downstream formulation in CAR-T culture cleanup applications.
  • Human T Cell Depletion Kit (RUO) RUO-grade kit for removing unwanted CD3+ T cells from samples, enabling cleaner engineered cell populations for research and process development applications.
  • Human PBMC Leukopak Isolation Kit Kit for isolating peripheral blood mononuclear cells from leukopak samples using buoyant microbubble technology, providing fast and gentle cell separation with high viability.
  • Human T Cell Isolation Kit Standard-scale kit for isolating T cells from human samples using buoyant microbubble technology, suitable for smaller cell input quantities in research settings.
  • Human CD4+ T Cell Isolation Kit Kit for isolating CD4+ helper T cells from human samples using negative selection microbubble technology without requiring magnetic columns.
  • Human CD14+ Monocyte Isolation Kit Kit for isolating CD14+ monocytes from human peripheral blood samples using antibody-functionalized buoyant microbubbles for rapid, gentle separation.
  • Human B Cell Isolation Kit Kit for isolating B cells from human samples using buoyant microbubble negative selection technology that preserves cell health and physiology.
  • Dead Cell Removal Microbubble Kit Kit utilizing Annexin V-coated microbubbles to selectively bind phosphatidylserine on dead cells, enabling removal of apoptotic cells from samples while preserving viable cell populations.
  • Human Red Blood Cell Depletion Microbubbles Microbubble kit for depleting red blood cells from human samples using buoyant separation technology, enabling rapid removal of RBC contamination.
  • Streptavidin Microbubbles Streptavidin-coated buoyant microbubbles that can be paired with biotinylated antibodies for custom cell separation applications, providing flexible labeling and separation capability.
  • Mouse T Cell Isolation Kit Kit for isolating T cells from mouse spleen or lymph node samples using negative selection microbubble technology at research scale.
  • Mouse B Cell Isolation Kit Kit for isolating B cells from mouse spleen samples using buoyant microbubble negative selection that maintains cell physiology without harsh mechanical forces.
  • Mouse CD4+ Isolation Kit Kit for isolating CD4+ T cells from mouse samples using microbubble-based negative selection at research scale.
  • Mouse Naive T Cell Isolation Kit Research-scale kit for isolating naive T cells from mouse samples using negative selection microbubble technology.
  • Mouse Naive CD4+ T Cell Isolation Kit Kit for isolating naive CD4+ T cells from mouse samples using buoyant microbubble technology without magnetic separation.
  • Human T Cell Selection, Activation, and Expansion Kit Kit combining T cell selection via microbubbles with activation and expansion reagents for a streamlined cell therapy workflow from selection through culture.

Quantifiable outcome

  • 40% reduction in overall therapeutic manufacturing costs
  • +6 more outcomes

Companies that use Akadeum Life Sciences

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Akadeum Life Sciences technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration7 records

Feature4 records

Akadeum Life Sciences partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core.

  • Charles River LaboratoriescoreTechnology or Integration · 9 December 2025Charles River is an inaugural member of the Akadeum CDMO Alliance Program, integrating GMP microbubble kits into their cell therapy manufacturing services. Collaboration includes application notes demonstrating workflow compatibility, efficiency, and performance comparing microbubble-based isolation against traditional magnetic methods.
  • ElevateBiocoreTechnology or Integration · 9 December 2025ElevateBio is an inaugural member of the Akadeum CDMO Alliance Program, offering cell therapy manufacturing services using Akadeum's GMP microbubble technology with early access to new kits in development.
  • BioIVTcoreStrategic or Co-development Partner · 1 October 2025Strategic collaboration to provide higher-quality T cells for cell therapy development, focusing on better-qualified leukopak materials. The microbubble-based separation process results in healthier T cells and more consistent workflow results.
  • Cayman ChemicalcoreChannel Partner/ Reseller/ Distributor · 25 September 2025Distribution partnership enabling Cayman Chemical to distribute Akadeum's buoyant microbubble cell isolation kits globally, expanding researcher access to this technology for advancing cell and gene therapy development.
  • Thermo Fisher ScientificcoreTechnology or IntegrationIntegration of Akadeum's GMP microbubble kits with Thermo Fisher's Rotea Counterflow Centrifugation System for automated cell washing, buffer exchange, and concentration workflows in cell therapy manufacturing.
  • CytivacoreTechnology or IntegrationIntegration with Cytiva's Sepax C-Pro Cell Processing System demonstrating high purity and recovery for CAR-T manufacturing workflows. NIH study also validated microbubble isolation with Sepax NeatCell protocol.
  • Fresenius KabicoreTechnology or IntegrationIntegration with Fresenius Kabi's Cue Cell Processing System for automated platelet depletion combined with Akadeum's in-bag T cell isolation, demonstrating equivalent performance to magnetic methods in half the time.
  • Wilson WolfcoreTechnology or IntegrationIntegration with Wilson Wolf G-Rex Bioreactor Platform for instrument-free, closed-system T cell isolation upstream of culture expansion. Microbubbles maintain T cell memory plasticity phenotypes important to therapeutic relevance.
  • Octane BiotechcoreTechnology or IntegrationIntegration with Octane Biotech Cocoon Platform for fully automated T cell enrichment from cryopreserved leukopaks, achieving 88-97% CD3+ purity and 50-86% recovery without magnets or beads.
  • MaxCytecoreTechnology or IntegrationIntegration with MaxCyte ExPERT GTx Electroporation Instrument demonstrating that microbubble-isolated cells show improved post-electroporation viability, higher expansion, and preserved stem-cell-like memory phenotypes.
  • LimulacoreTechnology or IntegrationIntegration with Limula LimONE Platform for fully automated, closed T cell enrichment embedded within end-to-end CAR-T workflow. Achieves PBMC-to-activation in approximately 1 hour 45 minutes within closed system.

Scale indicators7 records

Recent moves6 records

Expansion highlights7 records

Akadeum Life Sciences competitors and assessment

Company assessment

Direct peers

  • Miltenyi Biotec: The dominant incumbent in magnetic-activated cell sorting (MACS), Miltenyi sells separation reagents, instruments, and GMP cell therapy manufacturing services that directly compete with Akadeum's microbubble kits for T cell, B cell, and PBMC isolation in clinical and commercial cell therapy workflows.
  • STEMCELL Technologies: Provides EasySep immunomagnetic cell separation kits for research and GMP-grade cell isolation; directly competes with Akadeum's RUO and GMP cell separation kits across T cell, B cell, monocyte, and PBMC isolation applications.
  • MaxCyte: Provides the ExPERT GTx electroporation platform for cell engineering that integrates upstream/downstream with Akadeum's microbubble kits; overlapping footprint in GMP cell therapy manufacturing workflows and a complementary (rather than purely substitutive) peer.
  • Wilson Wolf: Manufacturer of G-Rex bioreactors used in cell therapy expansion that integrate with Akadeum's microbubble isolation kits; comparable as a focused cell therapy bioprocessing platform vendor serving the same customer base.

Broad incumbents

  • Thermo Fisher Scientific: Sells Dynabeads magnetic separation reagents and the Rotea counterflow centrifugation system integrated with Akadeum's kits; competes at the cell processing instrument and consumables layer across the cell therapy manufacturing value chain.
  • Cytiva: Supplies the Sepax C-Pro cell processing system integrated with Akadeum's microbubble kits for CAR-T manufacturing; also offers competing cell processing instruments and consumables broadly used across the cell therapy manufacturing space.
  • Beckman Coulter Life Sciences: A Danaher-owned life science tools provider offering cell sorting instrumentation (CytoFLEX, MoFlo Astrios) and reagents; competes as an incumbent in the broader cell separation and analysis category relevant to Akadeum's customer base.
  • BD Biosciences: Supplies FACSDiscover and BD CellView image-enabled cell sorters plus a broad reagents portfolio; an incumbent in cell sorting and separation used by Akadeum's customer base of cell therapy developers and CDMOs.
  • Bio-Techne: Sells cell separation and culture reagents (including the original T Cell Activation/Expansion portfolio) through its ProteinSimple and R&D Systems brands; an established life science tools incumbent overlapping with Akadeum's research and GMP reagent lines.

Emerging players

  • Sony Biotechnology: Supplies the CGX10 cell isolation system and MA900 multi-application cell sorter; a specialized cell separation instrumentation vendor with overlapping but more focused market presence compared to Akadeum's microbubble consumables approach.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Akadeum Life Sciences social profiles

Digital presence

Akadeum Life Sciences compliance and trust

Trust signal

Compliance11 records

Akadeum Life Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Akadeum Life Sciences leadership team

Management profile

Number of profiles

Profiles5 records

Akadeum Life Sciences funding detail

Funding detail

Funding overview

Funding rounds12 records

Investors17 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Akadeum Life Sciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Akadeum Life Sciences

What does Akadeum Life Sciences do?

Akadeum Life Sciences develops and manufactures buoyant microbubble-based cell separation products, including GMP-grade and research-use kits for T cell, B cell, monocyte, and PBMC isolation, plus the Alerion automated cell separation system. Its proprietary BACS (Buoyancy-Activated Cell Sorting) technology enables negative selection at clinical scale without magnets or centrifugation, supporting cell therapy manufacturing, CAR-T culture cleanup, and immunology research applications.

Is Akadeum Life Sciences a public or private company?

Akadeum Life Sciences is a private company. It is classified as venture growth investor backed and is currently operating.

When was Akadeum Life Sciences founded?

Akadeum Life Sciences was founded in 2014. It employs 11 to 50 people.

Where is Akadeum Life Sciences based?

Akadeum Life Sciences is headquartered in Ann Arbor, United States, in the North America region.

How does Akadeum Life Sciences make money?

Three revenue lines are on record. Cell Separation Kits (RUO and GMP) is the primary driver. The others are alerion Cell Separation System and CDMO Alliance Services.

Who are Akadeum Life Sciences's main competitors?

Direct peers on record are Miltenyi Biotec, STEMCELL Technologies, MaxCyte and Wilson Wolf. Broad incumbents are Thermo Fisher Scientific, Cytiva, Beckman Coulter Life Sciences, BD Biosciences and Bio-Techne. Sony Biotechnology is listed as an emerging player.

Does Akadeum Life Sciences have an API?

No public API is recorded for Akadeum Life Sciences.

What industry is Akadeum Life Sciences in?

Akadeum Life Sciences's product category is Cell Separation Technology. Its primary akta.pro industry code is HLAAABAG, Cell Therapy Manufacturing Platforms & Automation (closed systems, bioreactors, fill-finish), with a secondary code of HLAAAKAC, Cell Therapy Manufacturing Services (GMP, autologous/allogeneic). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
DVM 360New cancer therapy for dogs shows promiseLEAH Labs and Akadeum Life Sciences reported that two dogs with metastatic lymphoma achieved remission after receiving human CAR-T cell therapy isolated using Akadeum's technology. The study, conducted in collaboration with the University of Missouri, demonstrated significant tumor shrinkage and provided evidence that engineered T cells can be effectively tracked in vivo. This success highlights the potential for translating these veterinary findings into improved cancer therapies for humans.TechliFizzy Ann Arbor biotech startup gets $1.5 million in fundingAkadeum Life Sciences secured $1.5 million in funding from BioInflexion Point Partners and other investors to expand its cell isolation technology. The company, which won the CYTO Innovation Technology Showcase Award, utilizes glass-shelled microbubbles to isolate cells with high specificity. This investment supports Akadeum's plan to broaden its product line for diverse research labs globally.GlobeNewswireGlobal Cell Therapy Human Raw Materials Market Size/Share Worth USD 18.94 Billion by 2035 at a 16.3% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, GrHealthcare Foresights published a market research report projecting the global cell therapy human raw materials market will grow from USD 3.62 billion in 2025 to USD 18.94 billion by 2035, representing a compound annual growth rate of 16.3%. The report attributes growth to increasing cell therapy clinical trials, rising cancer and chronic disease prevalence, and expanded biomanufacturing capacity for CAR-T, stem cell, and regenerative medicine applications. Akadeum Life Sciences and BioIVT announced a strategic partnership in October 2025 to expand supply of leukopaks and T cells for cell therapy development.GlobeNewswire[Latest] Global Density Gradient Media Market Size/Share Worth USD 5.3 Billion by 2035 at a 11.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, GrowtHealthcare Foresights published a research report projecting the global density gradient media market to grow from USD 1.8 billion in 2025 to USD 5.3 billion by 2035, at a compound annual growth rate of 11.5%. The report identifies key growth drivers including increasing academic research funding, rising demand for cell-based therapies, and geographic expansion across North America and Asia-Pacific regions. Akadeum Life Sciences launched new buoyancy-based cell separation products in May 2023, while EDM Resources Inc. announced positive results from its Dense Media Separation Study in August 2025.PR NewswireAkadeum Life Sciences to Highlight How Microbubbles Enable Rapid Cell Therapy Manufacturing for Larger Patient Populations at Biotech Showcase 2026Akadeum Life Sciences CEO Brandon McNaughton will present at Biotech Showcase 2026 in San Francisco on January 12, 2026, highlighting the company's microbubble technology for scalable cell therapy manufacturing capable of producing hundreds of thousands of doses annually. The company submitted a Type II Drug Master File to the FDA in November 2025, a key regulatory milestone supporting adoption of its GMP products in regulated manufacturing environments, while data shows its workflow delivers 40% cost savings compared to traditional magnetic approaches.PR NewswireAkadeum Life Sciences Announces Establishment of the Akadeum CDMO Alliance ProgramAkadeum Life Sciences announced the establishment of the Akadeum CDMO Alliance, with Charles River and ElevateBio as inaugural members, to advance cell therapy manufacturing using Akadeum's microbubble technology. The alliance provides members early access to new kits, technical support, and training while offering cost savings of up to 40% on cell therapy manufacturing workflows. Akadeum CEO Brandon McNaughton stated the alliance aims to unite technologies and capabilities to increase access and reduce vein-to-vein time for cell therapies, with membership capped at five CDMOs and expansion expected to be complete in early 2026.PR NewswireAkadeum Life Sciences Announces Drug Master File Submission to the US FDA for GMP Microbubble Cell SeparationAkadeum Life Sciences has submitted a Type II Drug Master File to the U.S. FDA for its GMP BACS Microbubble Cell Separation products, demonstrating regulatory commitment and compliance with GMP, endotoxin, sterility, and viral safety standards for ancillary materials in cell and gene therapy. The company's microbubble technology reduces cell expansion time from 9 days to 5 days, cuts facility and labor costs by up to 30%, and delivers overall cost savings of up to 40% in cell therapy workflows. The filing supports clinical customers pursuing trials while reinforcing confidence in the safety and reliability of Akadeum's materials for cell therapy developers and manufacturers.PR NewswireAkadeum Life Sciences and BioIVT Collaborate to Provide Robust Starting Material to Developers of Cell Therapy ProductsAkadeum Life Sciences and BioIVT announced a collaboration to provide healthier T cells for cell therapy developers by combining Akadeum's Human T Cell Leukopak Isolation Kit-GMP with BioIVT's LEUKOMAX™ leukopaks. The in-bag microbubble-based separation enables faster cell separation workflows, reduced contamination risk, and more consistent results without requiring cell washing instrumentation. Both companies will continue generating additional workflow data to support more gentle approaches to cell therapy manufacturing.